NR5A1 and ovarian neoplasm: A methylation-sensitive restriction enzyme (Afe1) method (e.g. 19) was used to quantify site-specific methylation at −30 bp (compared to translation start) of the NR5A1 gene promoter in ovarian tumor tissue from patients with ovarian cancer and in matched normal tissue from the same patients (when available).